$NTGN Neon Therapeutics, Inc. Insider Trading Week 18/2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Neon Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Neon Therapeutics, Inc. in week 18/2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 06 2020 | NTGN | Neon Therapeutics, ... | Zausner Meryl | Director | Option Exercise | D | 16.00 | 14,000 | 224,000 | 0 | |
| May 06 2020 | NTGN | Neon Therapeutics, ... | Zausner Meryl | Director | Option Exercise | D | 9.65 | 40,000 | 386,000 | 0 | |
| May 06 2020 | NTGN | Neon Therapeutics, ... | Zausner Meryl | Director | Option Exercise | D | 4.64 | 18,500 | 85,840 | 0 | |
| May 06 2020 | NTGN | Neon Therapeutics, ... | TEPPER ROBERT I | Director | Option Exercise | D | 4.64 | 18,500 | 85,840 | 0 | |
| May 06 2020 | NTGN | Neon Therapeutics, ... | TEPPER ROBERT I | Director | Option Exercise | D | 16.00 | 14,000 | 224,000 | 0 | |
| May 06 2020 | NTGN | Neon Therapeutics, ... | TEPPER ROBERT I | Director | Sell | D | 0.00 | 9,741,636 | 0 | 0 | 9.7 M to 0 (-100.00 %) |
| May 06 2020 | NTGN | Neon Therapeutics, ... | SHERWIN STEPHEN A | Director | Option Exercise | D | 2.65 | 5,000 | 13,250 | 0 | |
| May 06 2020 | NTGN | Neon Therapeutics, ... | SHERWIN STEPHEN A | Director | Option Exercise | D | 4.64 | 18,500 | 85,840 | 0 | |
| May 06 2020 | NTGN | Neon Therapeutics, ... | SHERWIN STEPHEN A | Director | Option Exercise | D | 16.00 | 14,000 | 224,000 | 0 | |
| May 06 2020 | NTGN | Neon Therapeutics, ... | SHERWIN STEPHEN A | Director | Sell | D | 0.00 | 45,000 | 0 | 0 | 45 K to 0 (-100.00 %) |
| May 06 2020 | NTGN | Neon Therapeutics, ... | Pfeffer Cary | Director | Option Exercise | D | 4.64 | 18,500 | 85,840 | 0 | |
| May 06 2020 | NTGN | Neon Therapeutics, ... | Pfeffer Cary | Director | Option Exercise | D | 16.00 | 14,000 | 224,000 | 0 | |
| May 06 2020 | NTGN | Neon Therapeutics, ... | LANDER ERIC S | Director | Option Exercise | D | 4.64 | 18,500 | 85,840 | 0 | |
| May 06 2020 | NTGN | Neon Therapeutics, ... | LANDER ERIC S | Director | Option Exercise | D | 16.00 | 14,000 | 224,000 | 0 | |
| May 06 2020 | NTGN | Neon Therapeutics, ... | LANDER ERIC S | Director | Sell | D | 0.00 | 134,000 | 0 | 0 | 134 K to 0 (-100.00 %) |
| May 06 2020 | NTGN | Neon Therapeutics, ... | Kamen Robert | Director | Option Exercise | D | 4.64 | 18,500 | 85,840 | 0 | |
| May 06 2020 | NTGN | Neon Therapeutics, ... | Kamen Robert | Director | Option Exercise | D | 16.00 | 14,000 | 224,000 | 0 | |
| May 06 2020 | NTGN | Neon Therapeutics, ... | Bazemore Robert B | Director | Option Exercise | D | 4.64 | 18,500 | 85,840 | 0 | |
| May 06 2020 | NTGN | Neon Therapeutics, ... | Bazemore Robert B | Director | Option Exercise | D | 7.56 | 28,000 | 211,680 | 0 | |
| May 06 2020 | NTGN | Neon Therapeutics, ... | GAYNOR RICHARD | President of R&D | Option Exercise | D | 2.65 | 155,373 | 411,738 | 0 | |
| May 06 2020 | NTGN | Neon Therapeutics, ... | GAYNOR RICHARD | President of R&D | Option Exercise | D | 6.13 | 105,000 | 643,650 | 0 | |
| May 06 2020 | NTGN | Neon Therapeutics, ... | GAYNOR RICHARD | President of R&D | Option Exercise | D | 10.20 | 58,005 | 591,651 | 0 | |
| May 06 2020 | NTGN | Neon Therapeutics, ... | GAYNOR RICHARD | President of R&D | Sell | D | 0.00 | 210,410 | 0 | 0 | 210.4 K to 0 (-100.00 %) |
| May 06 2020 | NTGN | Neon Therapeutics, ... | Siegel Jolie | VP, General Counsel | Option Exercise | D | 12.00 | 100,000 | 1,200,000 | 0 | |
| May 06 2020 | NTGN | Neon Therapeutics, ... | Siegel Jolie | VP, General Counsel | Option Exercise | D | 6.13 | 60,000 | 367,800 | 0 | |
| May 06 2020 | NTGN | Neon Therapeutics, ... | Siegel Jolie | VP, General Counsel | Sell | D | 0.00 | 161,821 | 0 | 0 | 161.8 K to 0 (-100.00 %) |
| May 06 2020 | NTGN | Neon Therapeutics, ... | Al-Wakeel Yasir B. | Chief Financial Off ... | Option Exercise | D | 6.13 | 100,000 | 613,000 | 0 | |
| May 06 2020 | NTGN | Neon Therapeutics, ... | Al-Wakeel Yasir B. | Chief Financial Off ... | Option Exercise | D | 10.20 | 61,031 | 622,516 | 0 | |
| May 06 2020 | NTGN | Neon Therapeutics, ... | Al-Wakeel Yasir B. | Chief Financial Off ... | Option Exercise | D | 5.80 | 192,759 | 1,118,002 | 0 | |
| May 06 2020 | NTGN | Neon Therapeutics, ... | Al-Wakeel Yasir B. | Chief Financial Off ... | Sell | D | 0.00 | 196,965 | 0 | 0 | 197 K to 0 (-100.00 %) |
| May 06 2020 | NTGN | Neon Therapeutics, ... | O'Dowd Hugh | President & CEO | Option Exercise | D | 2.65 | 354,632 | 939,775 | 0 | |
| May 06 2020 | NTGN | Neon Therapeutics, ... | O'Dowd Hugh | President & CEO | Option Exercise | D | 6.13 | 200,000 | 1,226,000 | 0 | |
| May 06 2020 | NTGN | Neon Therapeutics, ... | O'Dowd Hugh | President & CEO | Option Exercise | D | 10.20 | 208,062 | 2,122,232 | 0 | |
| May 06 2020 | NTGN | Neon Therapeutics, ... | O'Dowd Hugh | President & CEO | Sell | D | 0.00 | 776,085 | 0 | 0 | 776.1 K to 0 (-100.00 %) |